APA (7th ed.) Citation

Ahmed A. Al-Kubaisi, Maysam Abdulrahman Ghazi, Nisreen Salah Majeed, Ekram R. Aldelaimi, & Hamid H. Enezei. (2024). Soluble urokinase plasminogen activator receptor (suPAR) is a potential biomarker of stage III-IV, grade C periodontitis through the impact of post-radiotherapy on head and neck cancer patients. BMC.

Chicago Style (17th ed.) Citation

Ahmed A. Al-Kubaisi, Maysam Abdulrahman Ghazi, Nisreen Salah Majeed, Ekram R. Aldelaimi, and Hamid H. Enezei. Soluble Urokinase Plasminogen Activator Receptor (suPAR) Is a Potential Biomarker of Stage III-IV, Grade C Periodontitis Through the Impact of Post-radiotherapy on Head and Neck Cancer Patients. BMC, 2024.

MLA (9th ed.) Citation

Ahmed A. Al-Kubaisi, et al. Soluble Urokinase Plasminogen Activator Receptor (suPAR) Is a Potential Biomarker of Stage III-IV, Grade C Periodontitis Through the Impact of Post-radiotherapy on Head and Neck Cancer Patients. BMC, 2024.